$144.00
-9.43-6.15%
Last update: Nov 6, 9:22 AM
Guardant Health Inc
GHNASDAQ
The average analyst price target for Guardant Health is $170.07, 18.1% above the current price. Of 26 analysts, 26 rate it Buy. Targets range from $60 to $225. The latest change came on Oct 27, 2026, when BTIG raised its price target on Guardant Health from $195 to $210 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 26 Analysts
Rating Trend — Last 9 Months
